Cepheid Shares Rise 7.5 Percent, Caliper Drops 3.6 Percent | GenomeWeb
Shares of Cepheid rose 7.5 percent for the five-day trading period ended Tuesday. The trading week was cut short a few hours on Tuesday in advance of the Independence Day holiday in the US.
 
Cepheid and Becton Dickinson were mentioned in an article in Friday’s edition of The Wall Street Journal focused on new testing methods for antibiotic resistance in hospitals. The firms make the only Food and Drug Administration-cleared molecular-based tests for methicillin-resistant Streptococcus aureus.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.